Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Immix Biopharma Inc (NASDAQ: IMMX) was $4.95 for the day, down -2.94% from the previous closing price of $5.1. In other words, the price has decreased by -$2.94 from its previous closing price. On the day, 0.9 million shares were traded. IMMX stock price reached its highest trading level at $5.29 during the session, while it also had its lowest trading level at $4.935.
Ratios:
Our analysis of IMMX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 10 ’25 when Rachman Ilya M bought 746 shares for $6.67 per share. The transaction valued at 4,976 led to the insider holds 1,141,683 shares of the business.
Morris Gabriel S bought 770 shares of IMMX for $5,067 on Dec 10 ’25. The CFO now owns 291,429 shares after completing the transaction at $6.58 per share. On Sep 17 ’25, another insider, Rachman Ilya M, who serves as the CEO and Chairman of the company, bought 2,500 shares for $2.02 each. As a result, the insider paid 5,050 and bolstered with 1,140,937 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 260842816 and an Enterprise Value of 151369504.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.31, which has changed by 1.2666667 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $7.73, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 5.63%, while the 200-Day Moving Average is calculated to be 73.79%.
Shares Statistics:
IMMX traded an average of 981.69K shares per day over the past three months and 814340 shares per day over the past ten days. A total of 52.70M shares are outstanding, with a floating share count of 33.53M. Insiders hold about 36.37% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for IMMX as of 1765756800 were 1746822 with a Short Ratio of 1.78, compared to 1763078400 on 1186085. Therefore, it implies a Short% of Shares Outstanding of 1746822 and a Short% of Float of 4.2299999999999995.
Earnings Estimates
A comprehensive evaluation of Immix Biopharma Inc (IMMX) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.68 and -$0.77 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is -$0.64, with 2.0 analysts recommending between -$0.64 and -$0.65.
